Augustin M, Reich K, Yamauchi P, Pinter A, et al. Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial. Br J Dermatol 2022 Jan 4. doi: 10.1111/bjd.20971.
PMID: 34981829